Stereotaxis (STXS) EBITDA Margin Growth (1y) (2011 - 2026)
Stereotaxis (STXS) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 314.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -233.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -912.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -306.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -418.00 |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 48.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -171.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -2,130.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 53.00 |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | -1,572.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,572.00 |
| Dec 31, 2025 | 5,493.00 |
| Sep 30, 2025 | -1,885.00 |
| Jun 30, 2025 | 8,854.00 |
| Mar 31, 2025 | -1,037.00 |
| Dec 31, 2024 | -411.00 |
| Sep 30, 2024 | 331.00 |
| Jun 30, 2024 | -6,659.00 |
| Mar 31, 2024 | 1,683.00 |
| Dec 31, 2023 | -5,516.00 |
| Sep 30, 2023 | -633.00 |
| Jun 30, 2023 | 1,704.00 |
| Mar 31, 2023 | -2,771.00 |
| Dec 31, 2022 | -2,039.00 |
| Sep 30, 2022 | -1,524.00 |
| Jun 30, 2022 | -4,672.00 |
| Mar 31, 2022 | -4,039.00 |
| Dec 31, 2021 | -2,340.00 |
| Sep 30, 2021 | -3,278.00 |
| Jun 30, 2021 | -152.00 |